FDA Inspection
XeCare LLCXeCare LLC – FDA Inspection, Jun 17, 2026
Record Details
This FDA Inspection record concerns XeCare LLC, with an inspection on June 17, 2026, issued by the Cincinnati District Office, covering human drugs.
View Company Profile
ID · 53b1a87c-13f7-43f4-b9ab-dc14c834f504
Inspection Facts
- Inspection number
- 1307174
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- FDCA 501(a)(2)(A)Beta-lactam, hazardous, highly potent drugs, prevention of cross-contamination
- FDCA 501(a)(2)(A)Exposed to lower quality air/ISO 5
- FDCA 501(a)(2)(A)Use of non-pharmaceutical, ingredients/processing aides
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.